المؤلفون: Reviriego, Eva, Ibargoyen Roteta, N., Carreguí Vilar, S., Mediavilla Serrano, L., Uceira Rey, S., Iglesias Casás S., Martín Casado, A., Toledo Chavarri, A., Ares Mateos, G., Montero Carcaboso, S., Castelló Zamora, B., Burgos Alonso, Natalia, Moreno Rodríguez, A., Hernández Tejada, N., Koetsenruyter, C.

مصطلحات موضوعية: natural childbirth, waterbirth, water immersion, childbirth, labor

وصف الملف: application/pdf

Relation: https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-023-05690-7; BMC Pregnancy and Childbirth 23 : (2023) // Article ID 395; http://hdl.handle.net/10810/61937

الاتاحة: http://hdl.handle.net/10810/61937
https://doi.org/10.1186/s12884-023-05690-7

المؤلفون: Esandi, ME, Gutierrez-Ibarluzea, I, Ibargoyen-Roteta, N, Godman, B

المصدر: International journal of technology assessment in health care. 36(1):50-57

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:143397847

المؤلفون: Gutiérrez-Ibarluzea, I, Ibargoyen-Roteta, N, Benguria-Arrate, G, Galnares-Cordero, L

المصدر: European Journal of Public Health ; volume 32, issue Supplement_3 ; ISSN 1101-1262 1464-360X

الاتاحة: https://doi.org/10.1093/eurpub/ckac129.085
https://academic.oup.com/eurpub/article-pdf/32/Supplement_3/ckac129.085/48593621/ckac129.085.pdf

المؤلفون: Medicina preventiva y salud pública, Prebentzio medikuntza eta osasun publikoa, Reviriego, Eva, Ibargoyen Roteta, N., Carreguí Vilar, S., Mediavilla Serrano, L., Uceira Rey, S., Iglesias Casás S., Martín Casado, A., Toledo Chavarri, A., Ares Mateos, G., Montero Carcaboso, S., Castelló Zamora, B., Burgos Alonso, Natalia, Moreno Rodríguez, A., Hernández Tejada, N., Koetsenruyter, C.

مصطلحات الفهرس: natural childbirth, waterbirth, water immersion, childbirth, labor, info:eu-repo/semantics/article

URL: http://hdl.handle.net/10810/61937
https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-023-05690-7
1471-2393
https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-023-05690-7

المؤلفون: Reviriego-Rodrigo, E., Ibargoyen-Roteta, N., Carreguí-Vilar, S., Mediavilla-Serrano, L., Uceira-Rey, S., Iglesias-Casás, S., Martín-Casado, A., Toledo-Chávarri, A., Ares-Mateos, G., Montero-Carcaboso, S., Castelló-Zamora, B., Burgos-Alonso, N., Moreno-Rodríguez, A., Hernández-Tejada, N., Koetsenruyter, C.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a27ec660814672e3d48e27b3bb25c9b

المؤلفون: Ibargoyen-Roteta, N, Mateos del Pino, M, Gutiérrez-Ibarluzea, I, Benguria-Arrate, G, Rada-Fernández de Jauregui, D, Domingo-Rico, C, Regidor Fuentes, I, González Santisteban, R, Armendáriz Cuñado, M, Jaio Atela, N

المصدر: GMS Health Technology Assessment; VOL: 14; DOC01 /20181105/

مصطلحات موضوعية: de-prescription, disinvestment, SYSADOA, chondroitin sulfate, diacerein, glucosamine, osteoarthritis, ddc: 610

Relation: Agencia Española de Medicamentos y Productos Sanitarios, Ministerio de Sanidad, Servicios Sociales e Igualdad. Informe de utilización de medicamentos U/AIN/V1/15012014. Utilización de medicamentos antiinflamatorios no esteroides (AINE) en España durante el periodo 2000-2012. 2014 Jan 27. Available from: http://aemps.gob.es/medicamentosUsoHumano/observatorio/docs/AINE.pdf; Ficha de evaluación terapéutica. Condroitín sulfato/Glucosamina (Droglican®) en artrosis. 2012 Mar. Available from: https://www.navarra.es/NR/rdonlyres/DABD1CC5-ED2A-496C-AE4D-D2FC34091E94/208204/FET_2012_3.pdf; Bae S, Kim S, Sung Y, et al. Effectiveness of Glucosamine/Condroitin in Osteoarthritis. NECA HTA Report NA 09-004. Seoul, Korea: NECA; 2009.; Bernal-Delgado E, García-Armesto S, Campillo-Artero C. Sirven los estudios de variabilidad geográfica de la práctica para informar la desinversión? Varias cautelas y algunas reflexiones [Are studies of geographical variation in medical practice useful in guiding decisions on disinvestment? Some pros and cons]. Gac Sanit. 2013 Jan-Feb;27(1):7-11. DOI:10.1016/j.gaceta.2012.02.004; Calvo Pita C. Fármacos sintomáticos de acción lenta y administración oral para la artrosis: dudosa eficacia en el control sintomatico y nula actividad condroprotectora. El Comprimido. 2010;18:1-7.; Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, Bradley JD, Bingham CO 3rd, Weisman MH, Jackson CG, Lane NE, Cush JJ, Moreland LW, Schumacher HR Jr, Oddis CV, Wolfe F, Molitor JA, Yocum DE, Schnitzer TJ, Furst DE, Sawitzke AD, Shi H, Brandt KD, Moskowitz RW, Williams HJ. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006 Feb 23;354(8):795-808. DOI:10.1056/NEJMoa052771; Comité de evaluación de nuevos medicamentos de Euskadi. Informe de Evaluación. Condroitín sulfato/glucosamina. Nuevo medicamento a examen No. 189. 2012. Available from: https://www.euskadi.eus/contenidos/informacion/medicamentos_atencion_primaria/es_def/adjuntos/C/condroitin-sulfato-glucosamina/condroitin sulfato_glucosamina_ficha_c.pdf; Elshaug AG, Moss JR, Littlejohns P, Karnon J, Merlin TL, Hiller JE. Identifying existing health care services that do not provide value for money. Med J Aust. 2009 Mar 2;190(5):269-73.; Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care. Ann Intern Med. 2003 Feb 18;138(4):273-87. DOI:10.7326/0003-4819-138-4-200302180-00006; Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care. Ann Intern Med. 2003 Feb 18;138(4):288-98. DOI:10.7326/0003-4819-138-4-200302180-00007; Gabbay J, le May A. Evidence based guidelines or collectively constructed "mindlines?" Ethnographic study of knowledge management in primary care. BMJ. 2004 Oct 30;329(7473):1013. DOI:10.1136/bmj.329.7473.1013; Gutiérrez-Ibarluzea I, Ibargoyen-Roteta N, Benguria-Arrate G, Rada D, Mateos M, Regidor I, Domingo C, González R, Galnares-Cordero L. Sysadoas. Condroprotectores en el tratamiento de la artrosis. Ministerio de Sanidad, Servicios Sociales e Igualdad. Servicio de Evaluación de Tecnologías Sanitarias del País Vasco; 2013. (Informes de Evaluación de Tecnologías Sanitarias: OSTEBA).; Gutiérrez-Ibarluzea I, Ibargoyen-Roteta N, Mateos-del Pino M, Benguria-Arrate G, Regidor-Fuentes I, Domingo-Rico C, González-Santisteban R, Rada-Fdz de Jauregi D. P168 Practice guidelines and professional mind-lines. Qualitative research on sysadoas for osteoarthritis. BMJ Qual Saf. 2013;22(Suppl 1):A1-A94. DOI:10.1136/bmjqs-2013-002293.190; Heller L. US glucosamine grows slow, lags global sales. 2009 Mar 02. Available from: https://www.nutraingredients-usa.com/Article/2009/03/02/US-glucosamine-grows-slow-lags-global-sales; Isasi Zaragoza C, Alcaraz Borrajo M, Sanz Sanz J. Fármacos de acción lenta para el tratamiento de la artrosis. Inf Ter Sist Nac Salud. 2004;28(6):145-50.; Jüni P, Reichenbach S, Dieppe P. Osteoarthritis: rational approach to treating the individual. Best Pract Res Clin Rheumatol. 2006 Aug;20(4):721-40. DOI:10.1016/j.berh.2006.05.002; Kim G, Park S, Hong S, et al. Clinical effectiveness of glucosamine for patients with osteoarthritis. NECA Rapid Review Report 11-002. Seoul, Korea: NECA; 2011.; Laegemiddelstyrelsen - Danish Medicines Agency. The reimbursement for glucosamine is removed on 28 November 2011. 2011 Oct 4. Available from: https://laegemiddelstyrelsen.dk/en/news/Nyheder revurdering tilskud arkiv/the-reimbursement-for-glucosamine-is-removed-on-28-november-2011; McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA. 2000 Mar 15;283(11):1469-75. DOI:10.1001/jama.283.11.1469; Nüesch E, Trelle S, Reichenbach S, Rutjes AW, Bürgi E, Scherer M, Altman DG, Jüni P. The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study. BMJ. 2009 Sep 7;339:b3244. DOI:10.1136/bmj.b3244; Nüesch E, Reichenbach S, Trelle S, Rutjes AW, Liewald K, Sterchi R, Altman DG, Jüni P. The importance of allocation concealment and patient blinding in osteoarthritis trials: a meta-epidemiologic study. Arthritis Rheum. 2009 Dec 15;61(12):1633-41. DOI:10.1002/art.24894; Reichenbach S, Sterchi R, Scherer M, Trelle S, Bürgi E, Bürgi U, Dieppe PA, Jüni P. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med. 2007 Apr 17;146(8):580-90. DOI:10.7326/0003-4819-146-8-200704170-00009; Rozendaal RM, Koes BW, van Osch GJ, Uitterlinden EJ, Garling EH, Willemsen SP, Ginai AZ, Verhaar JA, Weinans H, Bierma-Zeinstra SM. Effect of glucosamine sulfate on hip osteoarthritis: a randomized trial. Ann Intern Med. 2008 Feb 19;148(4):268-77. DOI:10.7326/0003-4819-148-4-200802190-00005; Sanfélix-Gimeno G, Peiró S, Librero J; Grupo de Investigación en Utilización de Medicamentos en el Sistema Nacional de Salud (Grupo IUM-SNS) de la Comunidad Valenciana. Variabilidad en la utilización de antihipertensivos entre las zonas básicas de salud de la Comunidad Valenciana [Variations in antihypertensive drug utilization among primary care areas in the autonomous region of Valencia (Spain)]. Gac Sanit. 2010 Sep-Oct;24(5):397-403. DOI:10.1016/j.gaceta.2010.05.004; Tandvårds- och läkemedelsförmånsverket. Glukosamin utesluts ur högkostnadsskyddet - Delbeslut i genomgången av smärtstillande och inflammationsdämpande läkemedel [Glucosamine excluded from the reimbursement system - Interim decision from the review of painkillers and anti-inflammatory medicines]. Solna: TVL; 2010. Available from: https://www.tlv.se/download/18.467926b615d084471ac33d03/1510316367373/sammanfattning/dglukosaminer-100216.pdf; Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, Hochberg MC, Wells G. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002946. DOI:10.1002/14651858.CD002946.pub2; Vlad SC, LaValley MP, McAlindon TE, Felson DT. Glucosamine for pain in osteoarthritis: why do trial results differ? Arthritis Rheum. 2007 Jul;56(7):2267-77. DOI:10.1002/art.22728; Wandel S, Jüni P, Tendal B, Nüesch E, Villiger PM, Welton NJ, Reichenbach S, Trelle S. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ. 2010 Sep 16;341:c4675. DOI:10.1136/bmj.c4675; http://dx.doi.org/10.3205/hta000130; http://nbn-resolving.de/urn:nbn:de:0183-hta0001306; http://www.egms.de/en/journals/hta/2018-14/hta000130.shtml

الاتاحة: https://doi.org/10.3205/hta000130
http://nbn-resolving.de/urn:nbn:de:0183-hta0001306
http://www.egms.de/en/journals/hta/2018-14/hta000130.shtml

المؤلفون: Ibargoyen-Roteta, N, Etxeandia-Ikobaltzeta, I

المصدر: G-I-N Conference 2012; 20120822-20120825; Berlin; DOCP007 /20120710/

مصطلحات موضوعية: ddc: 610

Relation: http://dx.doi.org/10.3205/12gin119; http://nbn-resolving.de/urn:nbn:de:0183-12gin1199; http://www.egms.de/en/meetings/gin2012/12gin119.shtml

الاتاحة: https://doi.org/10.3205/12gin119
http://nbn-resolving.de/urn:nbn:de:0183-12gin1199
http://www.egms.de/en/meetings/gin2012/12gin119.shtml

المؤلفون: Ibargoyen-Roteta, N, Etxeandia-Ikobaltzeta, I, Etxeberria-Agirre, A, Rotaeche-del Campo, R, Aldasoro-Ruiz, A, Lizarraga-Asparren, M, Elorz-Lambarri, J, Villar-Alvarez, M, Galardi-Andonegui, E, Irizar-Aranburu, M

مصطلحات موضوعية: Posters

وصف الملف: text/html

Relation: http://qualitysafety.bmj.com/cgi/content/short/22/Suppl_1/A74-b; http://dx.doi.org/10.1136/bmjqs-2013-002293.224

الاتاحة: http://qualitysafety.bmj.com/cgi/content/short/22/Suppl_1/A74-b
https://doi.org/10.1136/bmjqs-2013-002293.224

المؤلفون: Gutiérrez-Ibarluzea, I, Ibargoyen-Roteta, N, Mateos-del Pino, M, Benguria-Arrate, G, Regidor-Fuentes, I, Domingo-Rico, C, González-Santisteban, R, Rada-Fdz de Jauregi, D

مصطلحات موضوعية: Posters

وصف الملف: text/html

Relation: http://qualitysafety.bmj.com/cgi/content/short/22/Suppl_1/63-c; http://dx.doi.org/10.1136/bmjqs-2013-002293.190

الاتاحة: http://qualitysafety.bmj.com/cgi/content/short/22/Suppl_1/63-c
https://doi.org/10.1136/bmjqs-2013-002293.190

المؤلفون: Etxeandia-Ikobaltzeta, I, Ibargoyen-Roteta, N, Roteche-del Campo, R, Etxeberria-Agirre, A, Callén-Blecua, M

مصطلحات موضوعية: Posters

وصف الملف: text/html

Relation: http://qualitysafety.bmj.com/cgi/content/short/22/Suppl_1/A67-a; http://dx.doi.org/10.1136/bmjqs-2013-002293.201

الاتاحة: http://qualitysafety.bmj.com/cgi/content/short/22/Suppl_1/A67-a
https://doi.org/10.1136/bmjqs-2013-002293.201

المؤلفون: Ibargoyen-Roteta, N, Etxeandia-Ikobaltzeta, I, Zaragoza-Gaynor, G, Carrasco-Gimeno, J, Lizarraga-Azparren, M, Elorz-Lambarri, J, Villar-Alvarez, M

المصدر: BMJ Quality & Safety ; volume 22, issue Suppl 1, page A74.1-A74 ; ISSN 2044-5415 2044-5423

الاتاحة: http://dx.doi.org/10.1136/bmjqs-2013-002293.223
https://syndication.highwire.org/content/doi/10.1136/bmjqs-2013-002293.223

Additional Titles: HASH(0x563d4413bcb8)

المؤلفون: Erdos, J., Ibargoyen Roteta, N., Gutiérrez Ibarluzea, I.

مصطلحات الفهرس: WB 300-962 Therapeutics, W 100-275 Medical, dental and pharmaceutical service plans, WM 171 Depression. Depressive Disorder, Decision Support Document, NonPeerReviewed

URL: https://eprints.aihta.at/1130/1/DSD_107.pdf
https://eprints.aihta.at/1130/
https://eprints.aihta.at/1130

المؤلفون: Ibargoyen-Roteta N, Gutiérrez-Ibarluzea I, Asua, J.

الاتاحة: https://dx.doi.org/10.13140/rg.2.1.2960.8804
http://rgdoi.net/10.13140/RG.2.1.2960.8804

المؤلفون: Ibargoyen-Roteta, N., Etxeandia-Ikobaltzeta, I.

المصدر: G-I-N Conference 2012; 20120822-20120825; Berlin; DOCP007 /20120710/

مصطلحات موضوعية: ddc: 610, 610 Medical sciences, Medicine

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be6594b401e4441bc9d831eaf01d178f
http://nbn-resolving.de/urn:nbn:de:0183-12gin1199

المؤلفون: Ibargoyen-Roteta, N, Etxeandia-Ikobaltzeta, I, Aldasoro, A, Galardi-Andonegui, E, Callén-Blecua, M, Villar-Álvarez, M, Elorz-Lambarri, JJ

المصدر: G-I-N Conference 2012; 20120822-20120825; Berlin; DOCP087 /20120710/

مصطلحات موضوعية: animal structures, ddc: 610, embryonic structures, 610 Medical sciences, Medicine, human activities

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::778e70045ced6195430dd5db3bcee1af

المؤلفون: Ibargoyen-Roteta, N., Aguinaga-Ontoso, I., Fernandez-Benitez, M., Marin-Fernandez, B., FRANCISCO Guillen-Grima, Serrano-Monzo, I., Hermoso-De-Mendoza, J., Brun-Sandiumetge, C., Ferrer-Nadal, A., Irujo-Andueza, A.

المصدر: ResearcherID
Europe PubMed Central

مصطلحات موضوعية: Rhinitis, Allergic, Perennial, Risk Factors, Spain, Air Pollution, Indoor, Child, Preschool, Fungi, Humans, Dust, Child, Conjunctivitis, Allergic, Dermatitis, Atopic

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::07e9ac29bfd9dfb109b5a798e5bfff1e
https://pubmed.ncbi.nlm.nih.gov/17583099

المؤلفون: Varela-Lema L, Ruano-Ravina A, Mota TC, Ibargoyen-Roteta N, Imaz I, Gutiérrez-Ibarluzea I, Blasco-Amaro JA, Soto-Pedre E, Sampietro-Colom L

المصدر: International Journal of Technology Assessment in Health Care; Jul2012, Vol. 28 Issue 3, p285-293, 9p